The effectiveness of gabapentin and exercises in the treatment of carpal tunnel syndrome: a randomized clinical trial

Omid Hesami, Mahsa Haghighatzadeh, Behnam Safarpour Lima, Naghmeh Emadi, Shahin Salehi, Omid Hesami, Mahsa Haghighatzadeh, Behnam Safarpour Lima, Naghmeh Emadi, Shahin Salehi

Abstract

Carpal tunnel syndrome (CTS) is one of the reasons for labor abandonment due to inability and pain. The aim of this study was to evaluate the effectiveness of gabapentin and exercise training in the treatment of CTS and compare their effects. This single-blind clinical trial was conducted on patients referred to the Imam Hossein hospital's electrodiagnostic (EDX) unit. The patients randomly assigned into four groups: using nocturnal splint as an approved treatment in the control group; taking 300-mg gabapentin per night and using nocturnal splint; nerve and tendon gliding exercises and using nocturnal splint; and taking 300-mg gabapentin per night, performing same exercise as group 3 and using nocturnal splint. At baseline, four indicators were assessed in all patients, including the Boston carpal tunnel questionnaire, visual analogue scale (VAS), pinch and grip strength of the affected hand. One month after the beginning of intervention, participants were reassessed and compared for each of the four indicators. Using nocturnal splint along with exercise and gabapentin significantly improved VAS, pinch and grip strength in moderate CTS compared to control group that only used nocturnal splint. However in mild CTS, grip strength was not significantly higher compared to control group (P=0.048). Results of this study showed that use of splint alone in mild CTS is an appropriate and sufficient treatment; however, in moderate CTS, receiving gabapentin along with exercise and splinting showed better treatment results compared to splinting alone.

Keywords: Boston carpal tunnel questionnaire; Carpal tunnel syndrome; Exercise; Gabapentin; Grip and pinch strength; Visual analogue scale.

Conflict of interest statement

CONFLICT OF INTEREST No potential conflict of interest relevant to this article was reported.

Figures

Fig. 1
Fig. 1
Flow chart of trial and number of patients. From 230 patients of eligibility, 98 patients were randomized and 82 patients completed the course of intervention.

References

    1. Aroori S, Spence RA. Carpal tunnel syndrome. Ulster Med J. 2008;77:6–17.
    1. Backonja M, Beydoun A, Edwards KR, Schwartz SL, Fonseca V, Hes M, LaMoreaux L, Garofalo E. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial. JAMA. 1998;280:1831–1836.
    1. Ballestero-Pérez R, Plaza-Manzano G, Urraca-Gesto A, Romo-Romo F, Atín-Arratibel ML, Pecos-Martín D, Gallego-Izquierdo T, Romero-Franco N. Effectiveness of nerve gliding exercises on carpal tunnel syndrome: a systematic review. J Manipulative Physiol Ther. 2017;40:50–59.
    1. Baysal O, Altay Z, Ozcan C, Ertem K, Yologlu S, Kayhan A. Comparison of three conservative treatment protocols in carpal tunnel syndrome. Int J Clin Pract. 2006;60:820–828.
    1. Bialosky JE, Bishop MD, Price DD, Robinson ME, Vincent KR, George SZ. A randomized sham-controlled trial of a neurodynamic technique in the treatment of carpal tunnel syndrome. J Orthop Sports Phys Ther. 2009;39:709–723.
    1. Bland JD, Weller P, Rudolfer S. Questionnaire tools for the diagnosis of carpal tunnel syndrome from the patient history. Muscle Nerve. 2011;44:757–762.
    1. Brininger TL, Rogers JC, Holm MB, Baker NA, Li ZM, Goitz RJ. Efficacy of a fabricated customized splint and tendon and nerve gliding exercises for the treatment of carpal tunnel syndrome: a randomized controlled trial. Arch Phys Med Rehabil. 2007;88:1429–1435.
    1. Dale AM, Harris-Adamson C, Rempel D, Gerr F, Hegmann K, Silverstein B, Burt S, Garg A, Kapellusch J, Merlino L, Thiese MS, Eisen EA, Evanoff B. Prevalence and incidence of carpal tunnel syndrome in US working populations: pooled analysis of six prospective studies. Scand J Work Environ Health. 2013;39:495–505.
    1. Eftekharsadat B, Babaei-Ghazani A, Habibzadeh A. The efficacy of 100 and 300 mg gabapentin in the treatment of carpal tunnel syndrome. Iran J Pharm Res. 2015;14:1275–1280.
    1. Eftekharsadat B, Kazem Shakouri S, Shimia M, Rahbar M, Ghojazadeh M, Reza Rashidi M, Hadi Faraji M. Effect of E. laciniata (L) ointment on mild and moderate carpal tunnel syndrome: a double-blind, randomized clinical trial. Phytother Res. 2011;25:290–295.
    1. Hui AC, Wong SM, Leung HW, Man BL, Yu E, Wong LK. Gabapentin for the treatment of carpal tunnel syndrome: a randomized controlled trial. Eur J Neurol. 2011;18:726–730.
    1. Huisstede BM, Randsdorp MS, van den Brink J, Franke TPC, Koes BW, Hoogvliet P. Effectiveness of oral pain medication and corticosteroid injections for carpal tunnel syndrome: a systematic review. Arch Phys Med Rehabil. 2018;99:1609–1622.e10.
    1. Karne SS, Bhalerao NS. Carpal tunnel syndrome in hypothyroidism. J Clin Diagn Res. 2016;10:OC36–38.
    1. Levine DW, Simmons BP, Koris MJ, Daltroy LH, Hohl GG, Fossel AH, Katz JN. A self-administered questionnaire for the assessment of severity of symptoms and functional status in carpal tunnel syndrome. J Bone Joint Surg Am. 1993;75:1585–1592.
    1. Madenci E, Altindag O, Koca I, Yilmaz M, Gur A. Reliability and efficacy of the new massage technique on the treatment in the patients with carpal tunnel syndrome. Rheumatol Int. 2012;32:3171–3179.
    1. Nakamichi KI, Tachibana S. Enlarged median nerve in idiopathic carpal tunnel syndrome. Muscle Nerve. 2000;23:1713–1718.
    1. Osterman AL, Whitman M, Porta LD. Nonoperative carpal tunnel syndrome treatment. Hand Clin. 2002;18:279–289.
    1. Park YD, Park YJ, Park SS, Lee HL, Moon HH, Kim MK. Effects of taping therapy for carpal space expansion on electrophysiological change in patients with carpal tunnel syndrome. J Exerc Rehabil. 2017;13:359–362.
    1. Petit A, Ha C, Bodin J, Rigouin P, Descatha A, Brunet R, Goldberg M, Roquelaure Y. Risk factors for carpal tunnel syndrome related to the work organization: a prospective surveillance study in a large working population. Appl Ergon. 2015;47:1–10.
    1. Pourmemari MH, Shiri R. Diabetes as a risk factor for carpal tunnel syndrome: a systematic review and meta-analysis. Diabet Med. 2016;33:10–16.
    1. Premoselli S, Sioli P, Grossi A, Cerri C. Neutral wrist splinting in carpal tunnel syndrome: a 3- and 6-months clinical and neurophysiologic follow-up evaluation of night-only splint therapy. Eura Medicophys. 2006;42:121–126.
    1. Raja S, Carlos AJ. Carpal tunnel syndrome – current controversies. Orthop Trauma. 2015;29:273–277.
    1. Rowbotham M, Harden N, Stacey B, Bernstein P, Magnus-Miller L. Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial. JAMA. 1998;280:1837–1842.
    1. Rullán M, Bulilete O, Leiva A, Soler A, Roca A, González-Bals MJ, Lorente P, Llobera J, PHN group Efficacy of gabapentin for prevention of postherpetic neuralgia: study protocol for a randomized controlled clinical trial. Trials. 2017;18:24.
    1. Shiri R, Miranda H, Heliövaara M, Viikari-Juntura E. Physical work load factors and carpal tunnel syndrome: a population-based study. Occup Environ Med. 2009;66:368–373.
    1. Sim SE, Gunasagaran J, Goh KJ, Ahmad TS. Short-term clinical outcome of orthosis alone vs combination of orthosis, nerve, and tendon gliding exercises and ultrasound therapy for treatment of carpal tunnel syndrome. J Hand Ther. 2018 Feb 7; doi: 10.1016/j.jht.2018.01.004. [Epub]. pii: S0894-1130(17)30221-1.
    1. Stapleton MJ. Occupation and carpal tunnel syndrome. ANZ J Surg. 2006;76:494–496.
    1. Tal-Akabi A, Rushton A. An investigation to compare the effectiveness of carpal bone mobilisation and neurodynamic mobilisation as methods of treatment for carpal tunnel syndrome. Man Ther. 2000;5:214–222.
    1. Werner RA, Andary M. Electrodiagnostic evaluation of carpal tunnel syndrome. Muscle Nerve. 2011;44:597–607.

Source: PubMed

赞助者和合作者

医疗条件

药物干预

3
订阅